Stock Analysis

3 UK Penny Stocks Under £40M Market Cap

AIM:MHC
Source: Shutterstock

The UK market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines due to weak trade data from China, highlighting global economic interdependencies. Amidst these broader market fluctuations, investors may find opportunities in lesser-known areas such as penny stocks. Though the term "penny stocks" might seem outdated, it still represents an intriguing segment where smaller or newer companies can offer potential growth when backed by strong financial health.

Top 10 Penny Stocks In The United Kingdom

NameShare PriceMarket CapFinancial Health Rating
Polar Capital Holdings (AIM:POLR)£4.905£470.9M★★★★★★
ME Group International (LSE:MEGP)£2.09£776.24M★★★★★★
Tristel (AIM:TSTL)£3.70£178.85M★★★★★★
Begbies Traynor Group (AIM:BEG)£0.932£148.21M★★★★★★
Foresight Group Holdings (LSE:FSG)£3.81£417.98M★★★★★★
Secure Trust Bank (LSE:STB)£4.44£82.58M★★★★☆☆
Next 15 Group (AIM:NFG)£3.88£367.99M★★★★☆☆
Ultimate Products (LSE:ULTP)£1.05£87.29M★★★★★★
Helios Underwriting (AIM:HUW)£2.08£148.39M★★★★★☆
Stelrad Group (LSE:SRAD)£1.435£181.48M★★★★★☆

Click here to see the full list of 445 stocks from our UK Penny Stocks screener.

Let's explore several standout options from the results in the screener.

Deltic Energy (AIM:DELT)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Deltic Energy Plc is a natural resources investing company focused on the exploration, evaluation, and development of gas and oil licenses in the Southern and Central North Sea, with a market cap of £4.65 million.

Operations: Deltic Energy Plc has not reported any revenue segments.

Market Cap: £4.65M

Deltic Energy, with a market cap of £4.65 million, is pre-revenue and focuses on gas exploration in the North Sea. Recent developments at the Selene prospect have been promising, confirming a significant gas discovery with updated estimates of 131 BCF recoverable resources. The company has no long-term liabilities and maintains sufficient short-term assets to cover its liabilities. However, it faces challenges such as high share price volatility and limited cash runway under a year if free cash flow trends continue. Despite these hurdles, Deltic's debt-free status and strategic partnerships might support future project development.

AIM:DELT Debt to Equity History and Analysis as at Jan 2025
AIM:DELT Debt to Equity History and Analysis as at Jan 2025

MyHealthChecked (AIM:MHC)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: MyHealthChecked PLC develops, distributes, and commercializes at-home healthcare and wellness tests in the United Kingdom with a market cap of £9.99 million.

Operations: The company generates revenue of £9.39 million from its diagnostic healthcare products segment.

Market Cap: £9.99M

MyHealthChecked PLC, with a market cap of £9.99 million, is navigating the penny stock landscape by expanding its product offerings with newly registered phlebotomy test kits in the UK and EU. Despite being unprofitable, the company maintains a positive cash flow and has a stable cash runway exceeding three years. Its experienced management team and board bolster strategic decision-making. While short-term assets significantly cover liabilities, high share price volatility persists. The absence of debt provides financial flexibility as MyHealthChecked aims to commercialize its phlebotomy service in H1 2025, complementing existing at-home tests.

AIM:MHC Debt to Equity History and Analysis as at Jan 2025
AIM:MHC Debt to Equity History and Analysis as at Jan 2025

NAHL Group (AIM:NAH)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: NAHL Group Plc operates in the United Kingdom, offering products and services in the consumer legal services and catastrophic injury markets, with a market cap of £32.43 million.

Operations: The company generates revenue from two main segments: £15.37 million from Critical Care and £25.26 million from Consumer Legal Services.

Market Cap: £32.43M

NAHL Group Plc, with a market cap of £32.43 million, operates in the consumer legal services and catastrophic injury markets, generating significant revenue from these segments. The company's earnings have grown substantially by 172.9% over the past year, outpacing industry averages. Its debt is well managed with a net debt to equity ratio of 15.3%, and short-term assets exceed both short and long-term liabilities, indicating strong liquidity positions. However, recent guidance indicates an 8% decline in expected revenues for FY2024 due to reduced personal injury business income, aligning with market expectations but highlighting potential sector challenges.

AIM:NAH Debt to Equity History and Analysis as at Jan 2025
AIM:NAH Debt to Equity History and Analysis as at Jan 2025

Make It Happen

  • Click here to access our complete index of 445 UK Penny Stocks.
  • Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
  • Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Curious About Other Options?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About AIM:MHC

MyHealthChecked

Develops, distributes, and commercializes at-home healthcare and wellness tests in the United Kingdom.

Flawless balance sheet and slightly overvalued.

Community Narratives

Leading the Game with Growth, Innovation, and Exceptional Returns
Fair Value SEK 300.00|50.353% undervalued
Investingwilly
Investingwilly
Community Contributor
Why ASML Dominates the Chip Market
Fair Value €864.91|25.241000000000003% undervalued
yiannisz
yiannisz
Community Contributor
Global Payments will reach new heights with a 34% upside potential
Fair Value US$142.00|22.268% undervalued
Maxell
Maxell
Community Contributor